Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Institutional Biosafety Committee

In accordance with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, the National Institute of Environmental Health Sciences (NIEHS) has established an Institutional Biosafety Committee (IBC). The IBC is responsible for reviewing projects that involve, but are not limited to, recombinant DNA, RNAi, pathogens, human materials and other potentially infectious material, as well as transgenic animals. The IBC provides recommendations to the intramural community in matters pertaining to the control of biohazards associated with the use of microbiological agents and their vectors. It also represents the interests of the surrounding community with respect to public health and protection of the environment.

Membership Roster

Name Division/Organization
Rachel Boysen, Biosafety Specialist, IBC Contact, Executive Secretary OM / HSB
David Chen, Ph.D. DIR / VVC
Diane D’Agostin, M.S. DIR / STL
Francesco J. Demayo, Ph.D., IBC Chair, Deputy Chief, RDBL DIR / RDBL
Jacqueline Hamilton, M.A., BCBA Community Member
Justin Kosak, M.S. DIR / ESCBL
David M. Kurtz, D.V.M., Ph.D. DIR / CMB
Chris McGee, Biologist, Clinical Research Unit DIR / CRB
John McLamb, CHP, RRPT, Radiation Safety Officer OM / HSB
Steve Novak, CSP, Deputy Chief, HSB OM / HSB
Robert Petrovich, Ph.D., Protein Expression Core DIR / GISBL
Janine Santos, Group Leader, MTB, DTT NTP / SCT
Troy Weaver Community Member

IBC Calendar

Please make note of the 2021 Institutional Biosafety Committee (IBC) Calendar.

The IBC meets once every month, on the 2nd Thursday of each month. Submissions must be received by close of business (5:00 p.m.) at least 10 days prior for consideration at the IBC monthly meeting. You will find a below guide on submitting your biological material registrations through EHSA.

If you have any additional questions, please feel free to reach out to the HSB Biosafety Specialist at 984-287-3400.

Month Submission Deadline Meeting Date (All Thursdays)
January January 3 January 13
February January 31 February 10
March February 28 March 10
April April 4 April 14
May May 2 May 12
June May 30 June 9
July June 4 July 14
August August 1 August 11
September August 29 September 8
October October 3 October 13
November October 31 November 10
December November 28 December 8
  1. Principal Investigators are responsible for ensuring IBC review of the following:
    • Animal experiments requiring IBC approval with any of the above (prior to ACUC approval)
    • Biological Toxins (Select Agent toxins below the permissible toxin amount)
    • Human and Non-human Primate (NHP): blood, body fluids, tissues and primary or established cell lines
    • Pathogens/Microorganisms: Risk Group 1 or higher
    • Recombinant or Synthetic DNA work as defined by the NIH Guidelines
  2. Please be reminded that any ACUC Animal Study Protocol (ASP) that includes the use of biologicals agents, toxins, human-derived materials, or recombinant DNA, etc. requires a BIO Permit and must be approved prior to receiving ACUC approval.


IBC Charter NIEHS (150KB)

to Top